Generation and functional analysis of defective viral genomes during SARS-CoV-2 infection.
Terry ZhouNora J GilliamSizhen LiSimone SpaudauRaven M OsbornChristopher S AndersonThomas J MarianiJuilee ThakarStephen DewhurstDavid H MathewsLiang HuangYan SunPublished in: bioRxiv : the preprint server for biology (2022)
DVGs during natural SARS-CoV-2 infection. These findings set up the foundation for further mechanism studies of SARS-CoV-2 recombination and provide the evidence to harness DVGs’ immunostimulatory potential in the development of vaccine and antivirals for SARS-CoV-2.